- Product Details
Keywords
- Pipecuronium bromide (USAN)
- RGH 1106
- Arduan (TN)
Quick Details
- ProName: 4,4'-((2beta,3alpha,5alpha,16beta,17be...
- CasNo: 52212-02-9
- Molecular Formula: C35H62Br2N4O4
- Appearance: Solid
- Application: Pipecuronium Bromide is a muscle rela...
- DeliveryTime: large stock
- PackAge: According to the need to packing
- Port: Shanghai
- ProductionCapacity: 25 Kilogram/Week
- Purity: 98%
- Storage: Store at -20°C
- Transportation: Air,sea and courier
- LimitNum: 1 Gram
- Grade: Industrial Grade,Pharma Grade
Superiority
Product Name: Pipecuronium bromide
Synonyms: pipecuronium bromide;4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide;4,4'-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetoxy)androstane-2,16-diyl]bis[1,1-dimethylpiperazinium] dibromide;PIPECURIUM BROMIDE;Pipecuronium;PIPECURINIUM BROMIDE;4,4’-[(2β,3α,5α,16β,17β)-3,17-Bis(acetoxy)andrc~tane-2,16-diyl]bis(1,1-dimethylpiperazinium)dibromide;Ardtm
CAS: 52212-02-9
MF: C35H62Br2N4O4
MW: 762.69918
EINECS: 257-740-4
Product Categories:
Mol File: 52212-02-9.mol
Pipecuronium bromide Structure
Pipecuronium bromide Chemical Properties
Melting point 262-264° (dec)
alpha D25 +8.1° (c = 1 in water)
storage temp. Store at -20°C
solubility DMSO, Methanol (Slightly), Water (Slightly)
form Solid
color White to Off-White
CAS DataBase Reference 52212-02-9(CAS DataBase Reference)
Safety Information
Toxicity LD50 in mice, rats (mg/kg): 29.7, 172.6 i.v.; 70.6, 449.6 i.p.; 60.5, 455.8 s.c. (Kárpáti, Biro)
Details
Uses Pipecuronium Bromide is a muscle relaxant and an anaesthesia used in patients undergoing coronary artery bypass graft surgery.
Definition ChEBI: Pipecuronium bromide is a steroid ester.
Brand name Arduan (Organon).
General Description Pipecurium bromide, 4,4 -(3 ,17 -dihydroxy-5 -androstan-2 ,16 -ylene)bis(1,1-dimeth-ylpiperazinium)dibromide diacetate (Arduan), is anondepolarizing muscle relaxant similar, both chemicallyand clinically, to pancuronium bromide. It is a long-actingdrug indicated as an adjunct to anesthesia and in patients undergoingmechanical ventilation.
Pharmacology Pipecuronium bromide, an analogue of pancuronium, was developed in Hungary in 1980 and is marketed in Eastern Europe and the United S tates. The intubating dose is 0.07 mg kg–1. The onset time and time to recovery from block are similar to those of pancuronium, and excretion of the drug through the kidneys is significant (66%). In contrast to pancuronium, pipecuronium produces marked cardiovascular stability, having no vagolytic or sympathomimetic effects. It may therefore be useful during major surgery in patients with cardiac disease.